Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Cancer Cell|April 21, 2012
VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinomaOlga Mikhaylova, Yiwen Stratton, Daniel Hall, et al.
Cancer Chemotherapy and Pharmacology|September 1, 2022
Potentiation of temozolomide activity against glioblastoma cells by aromatase inhibitor letrozoleAniruddha S Karve, Janki M Desai, Nimita Dave, et al.
Cancer Research|June 3, 2004
Akt stimulates aerobic glycolysis in cancer cellsRebecca L Elstrom, Daniel E Bauer, Monica Buzzai, et al.
Molecular Cell|August 1, 2017
Focal Adhesion- and IGF1R-Dependent Survival and Migratory Pathways Mediate Tumor Resistance to mTORC1/2 InhibitionSang-Oh Yoon, Sejeong Shin, Florian A Karreth, et al.
The Journal of Cell Biology|May 14, 2021
Selective MAP1LC3C (LC3C) autophagy requires noncanonical regulators and the C-terminal peptideMegan E Bischoff, Yuanwei Zang, Johnson Chu, et al.
Cell Reports|March 2, 2017
Pharmacologic Targeting of S6K1 in PTEN-Deficient NeoplasiaHongqi Liu, Xizhi Feng, Kelli N Ennis, et al.
International Journal of Molecular Sciences|March 28, 2024
A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome ResistanceAniruddha S Karve, Janki M Desai, Sidharth N Gadgil, et al.
The Journal of Biological Chemistry|April 1, 2023
Microtubule-associated protein MAP1LC3C regulates lysosomal exocytosis and induces zinc reprogramming in renal cancer cellsRita Verma, Parul Aggarwal, Megan E Bischoff, et al.
Cancer Cell|December 18, 2014
TRPM3 and miR-204 establish a regulatory circuit that controls oncogenic autophagy in clear cell renal cell carcinomaDaniel P Hall, Nicholas G Cost, Shailaja Hegde, et al.
Pharmaceuticals (Basel, Switzerland)|February 2, 2021
Reuse of Molecules for Glioblastoma TherapyAbigail Koehler, Aniruddha Karve, Pankaj Desai, et al.
Pageof 7